In terms of KEGG or disease pathway, we observed the enrichment of targets involved in various cancers or cancer-related signaling processes such as Wnt, VEGF, ErbB signaling, mammary neoplasm, and endometrial cancer, among others. This evidence concerns the gene EGFR and cancer.